An investigator-initiated trial soon will evaluate Clinical Laserthermia Systems’ Tranberg Thermal therapy, a focal ablation therapy, for the treatment of prostate cancer patients who have up to medium-grade, localized tumors. The trial will take place at the Otto-von-Guericke-University Magdeburg, in Germany, through a collaboration between the medical center and the developing company. It is expected to recruit 10 participants starting in December, after receiving formal approval from an ethics committee and the regulatory agency for…
You must be logged in to read/download the full post.
The post Trial to Test Focal Laser Ablation Therapy for Localized Prostate Cancer appeared first on BioNewsFeeds.